GE Shares Climb 1.61% Amid Underperforming HealthCare Unit and 7.8% Post-Earnings Plunge Rank 88th in $0.99B Daily Volume

On August 12, 2025, General Electric (GE) saw a 1.61% rise in its stock price, with a trading volume of $0.99 billion, ranking 88th in market activity for the day. The company’s healthcare division, GE HealthCare Technologies (GEHC), has faced persistent underperformance against broader market benchmarks. Over the past 52 weeks, GEHC shares have fallen 12.5%, lagging the S&P 500’s 19.3% gain, while its year-to-date decline of 6.6% contrasts with the index’s 8.4% return. Despite Q2 revenue growth of 3.5% year-over-year to $5 billion and an upgraded 2025 adjusted EPS guidance to $4.43–$4.63, the stock plummeted 7.8% post-earnings release due to a 1.8% decline in adjusted EBIT and a 70-basis-point margin contraction.

Analyst sentiment remains cautiously optimistic. Of 19 covering the stock, 13 hold “Strong Buy” ratings, one “Moderate Buy,” and five “Hold.” Stifel Nicolaus analyst Rick Wise reiterated a “Buy” rating with a $90 price target, implying a 23.3% upside. The mean price target of $87.79 reflects a 20.3% premium, while the highest Street target of $106 signals a potential 45.2% gain. Forward-looking metrics, including a 0.6% expected EPS growth for fiscal 2025, underscore mixed near-term expectations despite consistent earnings beats in the past four quarters.

A backtested strategy of purchasing the top 500 stocks by daily volume and holding for one day generated a $2,340 profit from 2022 to 2025. However, the approach faced a maximum drawdown of -15.3% on October 27, 2022, highlighting inherent volatility risks despite potential gains.